Drug
Sevabertinib
Sevabertinib: highest development phase Phase 3, developed by Bayer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Bayer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Sevabertinib NCT06452277 | Phase 3 | Advanced Non-small Cell Lung Cancer, HER2 Mutation |
Latest
No recent events.
Follow Sevabertinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.